GERD device market to hit $1.9b as reflux care goes minimally invasive

India emerged as the fastest-growing market in APAC. 

The global gastroesophageal reflux disease (GERD) device market is expected to grow to $1.9b by 2036 due to a rise in the adoption of reflux diagnostic tools and growing use of minimally invasive anti-reflux procedures.

A Future Market Insights report said esophagoscopes and gastroscopes lead with 42% market share in 2026, ahead of manometry systems, pH monitoring systems, fundoplication devices, sphincter augmentation devices, and radiofrequency ablation devices.

By procedure, fundoplication accounts for 35% share in 2026, driven by refractory GERD cases requiring anatomical correction, followed by diagnostic procedures, radiofrequency thermal ablation, and magnetic sphincter augmentation.

By end user, hospitals dominate with a 60.0% share, ahead of diagnostic centres and ambulatory surgical centres.

Regionally, the United States is the fastest-growing major market at a 5.2% CAGR through 2036, followed by India (4.5%), China (3.6%), and Brazil (3.2%).

The report cites high procedure and implant costs, reimbursement constraints, training complexity for advanced procedures, and regulatory approval timelines as the main barriers to faster market growth.